Table 1 Description of included studies
Study | Setting | TD model structure and source | Screening uptake source | Baseline chlamydia prevalence source | Proportion asymptomatic | Duration of infection | Risk of transmission (baseline) | |
|---|---|---|---|---|---|---|---|---|
| Â | Â | No symptoms | Symptoms | |||||
Adams et al. 2007[14] | Comparison of screening strategies, UK | Individual based, Turner et al.[24] | Studies of opportunistic screening, England | Systematic review and UK survey data | 95.5% women; 100% men | 180Â days not seeking treatment | 30Â days seeking treatment | 0.0375 per act |
Andersen et al. 2006[15] | Home sampling screening with partner notification, Denmark | RCT of home sampling, Aarhus | Danish surveillance system and observational study in Aarhus | 70% women; 50% men | 370Â days in women; 200 days in men | 40Â days in women; 33 days in men | 0.11 per act | |
de Vries et al. 2006[17] | One off screening, the Netherlands | Compartmental, original model | Pilot of one off screening, the Netherlands | Pilot of one off screening, the Netherlands | 70% women; 50% men | 1Â year | 1Â month | 0.68 assume per partnership |
de Vries et al. 2008[16] | Repeat systematic screening, the Netherlands | As above | As above | As above | As above | As above | As above | As above |
Gillespie et al. 2012[18] | Opportunistic screening, Ireland | Individual based, Turner et al.[24] | Pilot of opportunistic screening, Ireland | UK data | 95.5% women; 100% men | 180Â days | 30Â days | 0.0375 per act |
Low et al. 2007[5] | Active screening, UK | ClaSS cross sectional study of screening uptake | ClaSS project | 70% women; 25% men | 200Â days | 40Â days in women; 33 days in men | 0.122 per act female to male; 0.154 per act male to female | |
Roberts et al. 2007[19] | Register based screening, England | Individual based, Kretzschmar et al. and Low et al.[4, 5, 48] | ClaSS cross sectional study of screening uptake | ClaSS project | 70% women; 25% men | 200Â days | 40Â days in women; 33 days in men | 0.061 per day female to male; |
| Â | 0.077 per day male to female | |||||||
Townshend and Turner 2000[21] | Three different screening strategies, UK | Compartmental, original model | Not presented | Sample of women presenting for cervical smear, UK | 75% women; 50% men | 2-3Â years | Not presented | Not presented |
Tuite et al. 2012[20] | Screening, Canada | Compartmental, Fisman et al.[23] | Testing patterns from Ontario Public Health Laboratory | Annual notifiable disease data, Canada | 90% women; 92% men | 1Â year untreated | Not presented | Present per partnership transmission probability* partner change rate |
Welte et al. 2000[22] | GP based opportunistic screening, Netherlands | GP pilot study, Amsterdam | GP pilot study, Amsterdam | 70% women; 50% men | Not presented | Not presented | 0.10 per act | |
Welte et al. 2005[6] | As above | As above | As above | As above | Not stated, assume as above | 370Â days in women; 200 days in men | 40Â days in women; 33 days in men | 0.11 per act |